Table:
begin	end	state
1	5	non-cytoplasmic
6	25	transmembrane
26	31	cytoplasmic
32	52	transmembrane
53	63	non-cytoplasmic
64	83	transmembrane
84	103	cytoplasmic
104	133	transmembrane
134	138	non-cytoplasmic
139	161	transmembrane
162	180	cytoplasmic
181	201	transmembrane
202	230	non-cytoplasmic
231	254	transmembrane
255	264	cytoplasmic
265	287	transmembrane
288	307	non-cytoplasmic
308	322	transmembrane
323	341	non-cytoplasmic
342	384	transmembrane
385	388	non-cytoplasmic
389	412	transmembrane
413	423	cytoplasmic
424	448	transmembrane
449	449	non-cytoplasmic

Input:
>AO353_05900 FitnessBrowser__pseudo3_N2E3:AO353_05900
MAPSFGYWLLVYAAIAIIALIVLIARYRLNPFIVITLVSIGLALLAGMPPSGVVGAYEAG
VGKTLGHIALVVALGTMLGKMMAESGGAEQMARTLIERFGEKNAHWAMVCIAFLVGLPLF
FEVGFVLLVPIAFTVARRVGVSILMVGLPMVAGLSVVHALVPPHPAAMLAVQAYQASVGQ
TLLYAILIGIPTAIIAGPLYAKFIVPRIQLPAENPLERQFIEREPRDRLPGFGITMATIL
LPVVLMLIGGWANLISTPGSGFNQFLLFIGNSVIALLLATLLSFWTLGLAQGFNRESILK
FTNECLAPTASITLLVGAGGGLNRILVDAGVTDQIVGLAHEFHLSPLLMGWLFAALMRIA
TGSATVAMTTASGVVAPVAIGLGYPHPELLVLATGAGSVIFSHVNDGGFWLVKEYFNMTV
TQTFKTWTVLETLISLVAFGLTLGLSYVL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server